Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Lymphoid 143Gastrointestinal 138Other hematologic neoplasm 123Breast 97Genitourinary 81Dermatologic 65Gynecologic 55Thoracic 53Head & Neck 52Sarcoma 47Plasma cell 47CNS 41Myeloid 40Tumor-Agnostic 34Other solid neoplasm 15Classical hematology 11Other neoplasm 9Endocrine 4Other 1NET 1

Conditions

Urinary Incontinence 1Sexual Dysfunction, Physiological 1Prostatic Neoplasms 1

Interventions

Exercise 27Metformin 24Methods 14Radiotherapy 13Early Intervention, Educational 13Educational Status 12Counseling 12Surveys and Questionnaires 10Standard of Care 10Nutrition Assessment 9Resistance Training 8Diet Therapy 8Cisplatin 8naloxegol 7Tirzepatide 7Diet 7alvimopan 6Psychiatric Rehabilitation 6Fibroblast Growth Factor 7 6Caloric Restriction 6Radiation 5Low-Level Light Therapy 5Liraglutide 5Injections 5Exenatide 5Dexamethasone 5Cryotherapy 5semaglutide 4angiotensin I (1-7) 4Vitamin D 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Biopsy × Other × Clear all
NCT00561314 2013-08-26

High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Completed
33 enrolled
GenitourinaryOther

Prostatic Neoplasms, Sexual Dysfunction, Physiological, Urinary Incontinence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡